| NCT03394755 |
Thrombosomes® in Bleeding Thrombocytopenic Patients |
https://ClinicalTrials.gov/show/NCT03394755 |
Active, not recruiting |
Cellphire, Inc. |
2019-08-03 |
| NCT03362177 |
Study of Romiplostim for Chemo-induced Thrombocytopenia in Adults Subjects With Gastrointestinal or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT03362177 |
Recruiting |
Amgen |
2022-01-17 |
| NCT03355742 |
XIENCE 28 Global Study |
https://ClinicalTrials.gov/show/NCT03355742 |
Completed |
Abbott Medical Devices |
2019-10-24 |
| NCT03333486 |
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer |
https://ClinicalTrials.gov/show/NCT03333486 |
Recruiting |
Roswell Park Cancer Institute |
2022-09-06 |
| NCT03304288 |
The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT03304288 |
Recruiting |
Peking University People’s Hospital |
2020-08-31 |
| NCT03275454 |
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT03275454 |
Recruiting |
Sanofi |
2022-05-31 |
| NCT03258866 |
The Study of Different Dose Rituximab in the Treatment of ITP |
https://ClinicalTrials.gov/show/NCT03258866 |
Completed |
Shandong University |
2015-12-31 |
| NCT03229746 |
Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT03229746 |
Completed |
Assiut University |
2018-06-01 |
| NCT03201848 |
The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT03201848 |
Recruiting |
Qidong Gaitianli Medicines Co., Ltd |
2021-12-31 |
| NCT03177629 |
H. Pylori Eradication for Moderate ITP |
https://ClinicalTrials.gov/show/NCT03177629 |
Recruiting |
Seoul National University Hospital |
2020-06-30 |
| NCT03172676 |
Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura |
https://ClinicalTrials.gov/show/NCT03172676 |
Recruiting |
Assiut University |
2020-06-01 |
| NCT03156452 |
Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate |
https://ClinicalTrials.gov/show/NCT03156452 |
Active, not recruiting |
University Hospitals Bristol NHS Foundation Trust |
2020-02-13 |
| NCT03154385 |
Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT03154385 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2019-11-13 |
| NCT03148912 |
Optimizing the Diagnosis of Heparin Induced Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT03148912 |
Recruiting |
Ottawa Hospital Research Institute |
2020-06-30 |
| NCT03147638 |
Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) |
https://ClinicalTrials.gov/show/NCT03147638 |
Recruiting |
Marshall University |
2019-01-11 |
| NCT03136445 |
TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT03136445 |
Recruiting |
NHS Blood and Transplant |
2020-12-30 |
| NCT03102593 |
A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP |
https://ClinicalTrials.gov/show/NCT03102593 |
Completed |
argenx BVBA |
2019-04-09 |
| NCT03059030 |
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT03059030 |
Recruiting |
Northwestern University |
2020-04-01 |
| NCT03010202 |
The PROLONG Trial - Rituximab Maintenance Therapy in ITP |
https://ClinicalTrials.gov/show/NCT03010202 |
Recruiting |
Ostfold Hospital Trust |
2023-12-31 |
| NCT02964325 |
Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT02964325 |
Recruiting |
Terumo BCTbio |
2021-11-30 |
| NCT02948283 |
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02948283 |
Active, not recruiting |
City of Hope Medical Center |
2020-10-31 |
| NCT02912208 |
Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT02912208 |
Recruiting |
Associazione Qol-one |
2019-08-31 |
| NCT02868099 |
Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT02868099 |
Completed |
Kyowa Hakko Kirin China Pharmaceutical Co., LTD. |
2017-02-28 |
| NCT02868060 |
Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT02868060 |
Completed |
Kyowa Hakko Kirin China Pharmaceutical Co., LTD. |
2017-08-31 |
| NCT02859909 |
This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT02859909 |
Completed |
Biotest |
2018-12-31 |
| NCT02845609 |
Efficacy of Sialic Acid GNE Related Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT02845609 |
Completed |
Hadassah Medical Organization |
2017-09-30 |
| NCT02783313 |
Pathogen Reduction Evaluation & Predictive Analytical Rating Score |
https://ClinicalTrials.gov/show/NCT02783313 |
Completed |
Sanquin Research & Blood Bank Divisions |
2016-04-30 |
| NCT02718716 |
Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT02718716 |
Completed |
UCB Pharma |
2019-02-28 |
| NCT02707497 |
The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia |
https://ClinicalTrials.gov/show/NCT02707497 |
Recruiting |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2021-10-31 |
| NCT02679443 |
Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy |
https://ClinicalTrials.gov/show/NCT02679443 |
Completed |
Postgraduate Institute of Medical Education and Research |
2016-12-31 |
| NCT03090919 |
The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis |
https://ClinicalTrials.gov/show/NCT03090919 |
Recruiting |
University of Kentucky |
2020-12-31 |
| NCT02578901 |
American Trial Using Tranexamic Acid in Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT02578901 |
Active, not recruiting |
University of Washington |
2020-06-30 |
| NCT02556814 |
Caffeic Acid Combining High-dose Dexamethasone in Management of ITP |
https://ClinicalTrials.gov/show/NCT02556814 |
Completed |
Shandong University |
2018-03-31 |
| NCT02530515 |
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02530515 |
Completed |
M.D. Anderson Cancer Center |
2018-04-30 |
| NCT02501434 |
Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin |
https://ClinicalTrials.gov/show/NCT02501434 |
Recruiting |
University of Louisville |
2019-03-31 |
| NCT02487563 |
Prospective Study of Patients With Thrombocytopenia Following HSCT |
https://ClinicalTrials.gov/show/NCT02487563 |
Completed |
The First Affiliated Hospital of Soochow University |
2019-04-12 |
| NCT02422394 |
Eltrombopag for Inherited Thrombocytopenias |
https://ClinicalTrials.gov/show/NCT02422394 |
Completed |
IRCCS Policlinico S. Matteo |
2018-03-31 |
| NCT02402998 |
Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia |
https://ClinicalTrials.gov/show/NCT02402998 |
Active, not recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-05-22 |
| NCT02391272 |
A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy |
https://ClinicalTrials.gov/show/NCT02391272 |
Completed |
Shandong University |
2015-11-30 |
| NCT02389621 |
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures |
https://ClinicalTrials.gov/show/NCT02389621 |
Completed |
Shionogi Inc. |
2017-04-05 |
| NCT04224688 |
A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT04224688 |
Recruiting |
UCB Pharma |
2022-07-31 |
| NCT02351622 |
Caffeic Acid Tablets as a Second-line Therapy for ITP |
https://ClinicalTrials.gov/show/NCT02351622 |
Completed |
Shandong University |
2013-12-31 |
| NCT02335268 |
VALIDATION OF A PREDICTIVE MODEL OF RESPONSE TO ROMIPLOSTIM IN PATIENTS WITH IPSS LOW OR INTERMEDIATE-1 RISK MDS AND THROMBOCYTOPENIA |
https://ClinicalTrials.gov/show/NCT02335268 |
Recruiting |
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH |
2020-06-30 |
| NCT02334813 |
Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT02334813 |
Completed |
University Hospital, Essen |
2015-01-31 |
| NCT02323178 |
A Study of Eltrombopag in Patients With CMML and Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT02323178 |
Active, not recruiting |
Groupe Francophone des Myelodysplasies |
2018-12-31 |
| NCT02314273 |
Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL |
https://ClinicalTrials.gov/show/NCT02314273 |
Completed |
Shanghai Children’s Medical Center |
2014-04-30 |
| NCT02298933 |
Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT02298933 |
Completed |
National Institutes of Health Clinical Center (CC) |
2017-08-08 |
| NCT02287649 |
Polymorphism and Auto-reactive B and T Cells Subsets in Adult’s Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT02287649 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2015-10-02 |
| NCT02267993 |
Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients |
https://ClinicalTrials.gov/show/NCT02267993 |
Completed |
Institute of Hematology & Blood Diseases Hospital |
2018-08-01 |
| NCT02227693 |
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT02227693 |
Completed |
Eisai Inc. |
2015-04-01 |
| NCT02153060 |
An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT02153060 |
Completed |
Shandong University |
2015-01-31 |
| NCT02139501 |
An Investigation of rhTPO With Different Frequencies in the Management of ITP |
https://ClinicalTrials.gov/show/NCT02139501 |
Completed |
Shandong University |
2015-01-31 |
| NCT02104440 |
Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro |
https://ClinicalTrials.gov/show/NCT02104440 |
Completed |
Red de Terapia Celular |
2017-03-31 |
| NCT02078284 |
Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets |
https://ClinicalTrials.gov/show/NCT02078284 |
Completed |
U.S. Army Medical Research and Development Command |
2016-07-31 |
| NCT02074436 |
PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) |
https://ClinicalTrials.gov/show/NCT02074436 |
Recruiting |
Emory University |
2021-05-31 |
| NCT02063789 |
An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT02063789 |
Completed |
Green Cross Corporation |
2016-04-30 |
| NCT01289509 |
A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01289509 |
Completed |
Eisai Inc. |
2011-03-31 |
| NCT01286038 |
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT01286038 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2020-09-30 |
| NCT02039076 |
A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects |
https://ClinicalTrials.gov/show/NCT02039076 |
Completed |
Eisai Inc. |
2014-06-30 |
| NCT04274452 |
A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT04274452 |
Recruiting |
argenx BVBA |
2021-09-01 |
| NCT01980030 |
Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell |
https://ClinicalTrials.gov/show/NCT01980030 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2015-12-31 |
| NCT01976104 |
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure |
https://ClinicalTrials.gov/show/NCT01976104 |
Completed |
Eisai Inc. |
2017-01-30 |
| NCT01974401 |
Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia |
https://ClinicalTrials.gov/show/NCT01974401 |
Completed |
Mashhad University of Medical Sciences |
2011-03-31 |
| NCT01972529 |
Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure |
https://ClinicalTrials.gov/show/NCT01972529 |
Completed |
Eisai Inc. |
2017-01-26 |
| NCT01966367 |
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01966367 |
Active, not recruiting |
Columbia University |
2022-01-31 |
| NCT01965626 |
A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP |
https://ClinicalTrials.gov/show/NCT01965626 |
Completed |
Shandong University |
2018-05-31 |
| NCT01963260 |
Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001) |
https://ClinicalTrials.gov/show/NCT01963260 |
Completed |
Merck Sharp & Dohme Corp. |
2015-04-26 |
| NCT01957176 |
A Rollover Study to Provide Continued Treatment With Eltrombopag |
https://ClinicalTrials.gov/show/NCT01957176 |
Active, not recruiting |
Novartis |
2024-01-01 |
| NCT01929980 |
Bortezomib to Treat Significant Complication of HSCT |
https://ClinicalTrials.gov/show/NCT01929980 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2014-05-31 |
| NCT01880047 |
Safety and Efficacy of Eltrombopag at Escalated Doses |
https://ClinicalTrials.gov/show/NCT01880047 |
Completed |
Weill Medical College of Cornell University |
2017-02-15 |
| NCT01808521 |
A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura |
https://ClinicalTrials.gov/show/NCT01808521 |
Completed |
Bloodworks |
2017-07-31 |
| NCT01791101 |
Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. |
https://ClinicalTrials.gov/show/NCT01791101 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT01789762 |
Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process |
https://ClinicalTrials.gov/show/NCT01789762 |
Completed |
Etablissement Français du Sang |
2016-01-31 |
| NCT01727401 |
Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT01727401 |
Active, not recruiting |
G. d’Annunzio University |
2020-12-31 |
| NCT01719692 |
Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT01719692 |
Completed |
Institute of Hematology & Blood Diseases Hospital |
2015-10-31 |
| NCT01667263 |
The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT01667263 |
Completed |
Peking University People’s Hospital |
2016-07-01 |
| NCT01657552 |
Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT01657552 |
Completed |
GlaxoSmithKline |
2012-10-26 |
| NCT01621204 |
A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients |
https://ClinicalTrials.gov/show/NCT01621204 |
Completed |
McMaster University |
2019-06-30 |
| NCT01610180 |
Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs) |
https://ClinicalTrials.gov/show/NCT01610180 |
Completed |
Fondazione Progetto Ematologia |
2018-06-30 |
| NCT01586455 |
Human Placental-Derived Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01586455 |
Active, not recruiting |
New York Medical College |
2019-06-30 |
| NCT01568333 |
A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT01568333 |
Completed |
Shandong University |
2017-10-31 |
| NCT01566695 |
The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS) |
https://ClinicalTrials.gov/show/NCT01566695 |
Active, not recruiting |
Celgene |
2019-01-25 |
| NCT01529827 |
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01529827 |
Completed |
Roswell Park Cancer Institute |
2015-05-28 |
| NCT01520909 |
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. |
https://ClinicalTrials.gov/show/NCT01520909 |
Completed |
GlaxoSmithKline |
2014-01-31 |
| NCT01506414 |
Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT01506414 |
Completed |
Shandong University |
2013-08-31 |
| NCT01488565 |
A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT01488565 |
Completed |
Peter MacCallum Cancer Centre, Australia |
2014-05-31 |
| NCT01481220 |
Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) |
https://ClinicalTrials.gov/show/NCT01481220 |
Completed |
Nordic MDS Group |
2013-05-31 |
| NCT01444417 |
Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients |
https://ClinicalTrials.gov/show/NCT01444417 |
Completed |
Amgen |
2015-02-28 |
| NCT01440374 |
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01440374 |
Completed |
Novartis |
2015-03-31 |
| NCT01438840 |
Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02) |
https://ClinicalTrials.gov/show/NCT01438840 |
Completed |
Eisai Inc. |
2013-11-30 |
| NCT01428635 |
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy |
https://ClinicalTrials.gov/show/NCT01428635 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-01-31 |
| NCT01355289 |
Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501 |
https://ClinicalTrials.gov/show/NCT01355289 |
Completed |
Eisai Inc. |
2014-02-28 |
| NCT01327872 |
Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01327872 |
Completed |
Eisai Inc. |
2011-04-30 |
| NCT04420494 |
Umbilical Cord Blood Treatment for Refractory Immune Cytopenia |
https://ClinicalTrials.gov/show/NCT04420494 |
Recruiting |
Peking Union Medical College Hospital |
2022-04-20 |
| NCT04368598 |
The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP |
https://ClinicalTrials.gov/show/NCT04368598 |
Recruiting |
Peking University People’s Hospital |
2020-12-31 |
| NCT04226950 |
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in the Treatment of Childhood Essential Thrombocythemia |
https://ClinicalTrials.gov/show/NCT04226950 |
Recruiting |
Institute of Hematology & Blood Diseases Hospital |
2022-07-20 |
| NCT04217148 |
The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT04217148 |
Recruiting |
Peking University People’s Hospital |
2022-12-31 |
| NCT04089267 |
Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT04089267 |
Completed |
Shenyang Sunshine Pharmaceutical Co., LTD. |
2018-12-31 |
| NCT04083014 |
Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia |
https://ClinicalTrials.gov/show/NCT04083014 |
Recruiting |
Peking Union Medical College Hospital |
2022-08-20 |
| NCT04056195 |
Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT04056195 |
Recruiting |
Oscotec Inc. |
2021-02-28 |
| NCT04039477 |
A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP |
https://ClinicalTrials.gov/show/NCT04039477 |
Recruiting |
Kezar Life Sciences, Inc. |
2020-12-31 |
| NCT04014166 |
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT04014166 |
Recruiting |
Institute of Hematology & Blood Diseases Hospital |
2021-12-31 |
| NCT03976882 |
Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy. |
https://ClinicalTrials.gov/show/NCT03976882 |
Recruiting |
Jiangsu HengRui Medicine Co., Ltd. |
2020-08-30 |
| NCT03951623 |
The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients |
https://ClinicalTrials.gov/show/NCT03951623 |
Recruiting |
Hutchison Medipharma Limited |
2021-12-31 |
| NCT03939637 |
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children |
https://ClinicalTrials.gov/show/NCT03939637 |
Recruiting |
Baylor College of Medicine |
2022-05-01 |
| NCT03937154 |
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer |
https://ClinicalTrials.gov/show/NCT03937154 |
Recruiting |
Amgen |
2022-03-28 |
| NCT03866798 |
Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT03866798 |
Recruiting |
Octapharma |
2022-03-31 |
| NCT03830749 |
Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura |
https://ClinicalTrials.gov/show/NCT03830749 |
Recruiting |
Humanity & Health Medical Group Limited |
2020-12-31 |
| NCT03815175 |
XIENCE 28 USA Study |
https://ClinicalTrials.gov/show/NCT03815175 |
Active, not recruiting |
Abbott Medical Devices |
2020-12-31 |
| NCT03771378 |
Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT03771378 |
Recruiting |
Wuhan Union Hospital, China |
2020-05-01 |
| NCT03712618 |
The SOLID Platelet Study |
https://ClinicalTrials.gov/show/NCT03712618 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-12-31 |
| NCT03701217 |
Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML |
https://ClinicalTrials.gov/show/NCT03701217 |
Recruiting |
Nanfang Hospital of Southern Medical University |
2019-09-30 |
| NCT03692754 |
Atorvastatin in Management of Newly Diagnosed ITP |
https://ClinicalTrials.gov/show/NCT03692754 |
Recruiting |
Shandong University |
2021-12-01 |
| NCT03664518 |
to Evaluate the Efficacy and Safety of Eltrombopag for Thrombocytopenia With Chronic HBV Infection |
https://ClinicalTrials.gov/show/NCT03664518 |
Recruiting |
Institute of Hematology & Blood Diseases Hospital |
2019-10-31 |
| NCT03638817 |
Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT03638817 |
Recruiting |
University Hospital, Toulouse |
2022-08-31 |
| NCT03633019 |
High-dose Use of rhTPO in CIT Patients |
https://ClinicalTrials.gov/show/NCT03633019 |
Recruiting |
First Affiliated Hospital Xi’an Jiaotong University |
2019-11-30 |
| NCT03603132 |
A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics |
https://ClinicalTrials.gov/show/NCT03603132 |
Completed |
Jiangsu HengRui Medicine Co., Ltd. |
2018-08-17 |
| NCT03567798 |
Thrombocytopenia Induced by Chemotherapy |
https://ClinicalTrials.gov/show/NCT03567798 |
Completed |
Socrates School Of Health |
2017-11-20 |
| NCT03561909 |
Kinetics of Blood Platelets Transfused to Healthy Subjects |
https://ClinicalTrials.gov/show/NCT03561909 |
Completed |
Prophylix Pharma AS |
2018-12-10 |
| NCT03515096 |
Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT |
https://ClinicalTrials.gov/show/NCT03515096 |
Recruiting |
Shenzhen Second People’s Hospital |
2020-12-01 |
| NCT03513328 |
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03513328 |
Recruiting |
University of Florida |
2021-06-30 |
| NCT03471078 |
Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers |
https://ClinicalTrials.gov/show/NCT03471078 |
Recruiting |
Dova Pharmaceuticals |
2020-11-30 |
| NCT03421184 |
Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03421184 |
Recruiting |
University Hospital, Bordeaux |
2020-11-30 |
| NCT01224496 |
Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders |
https://ClinicalTrials.gov/show/NCT01224496 |
Completed |
Singapore General Hospital |
2011-08-31 |
| NCT01165996 |
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT01165996 |
Completed |
Case Comprehensive Cancer Center |
2011-12-31 |
| NCT01163110 |
Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy |
https://ClinicalTrials.gov/show/NCT01163110 |
Completed |
Midwestern Regional Medical Center |
2007-06-30 |
| NCT01147809 |
Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag |
https://ClinicalTrials.gov/show/NCT01147809 |
Completed |
GlaxoSmithKline |
2015-01-31 |
| NCT01143038 |
Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim |
https://ClinicalTrials.gov/show/NCT01143038 |
Completed |
Amgen |
2013-09-20 |
| NCT01133860 |
Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease |
https://ClinicalTrials.gov/show/NCT01133860 |
Completed |
IRCCS Policlinico S. Matteo |
2010-06-30 |
| NCT01129024 |
An Open-label Safety Study of S-888711 |
https://ClinicalTrials.gov/show/NCT01129024 |
Completed |
Shionogi Inc. |
2011-08-31 |
| NCT01071954 |
A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura |
https://ClinicalTrials.gov/show/NCT01071954 |
Completed |
Amgen |
2017-01-12 |
| NCT01002755 |
Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
https://ClinicalTrials.gov/show/NCT01002755 |
Completed |
M.D. Anderson Cancer Center |
2018-01-31 |
| NCT01000051 |
Eltrombopag for Post Transplant Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT01000051 |
Completed |
M.D. Anderson Cancer Center |
2018-04-04 |
| NCT00961064 |
A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS) |
https://ClinicalTrials.gov/show/NCT00961064 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2017-08-10 |
| NCT00948792 |
Study of the Effect of Differing Platelet Transfusion Times in Neonates |
https://ClinicalTrials.gov/show/NCT00948792 |
Completed |
University of Oklahoma |
2010-12-31 |
| NCT00931762 |
Safety and Efficacy of Panobinostat in Patients With Primary Myelofibrosis |
https://ClinicalTrials.gov/show/NCT00931762 |
Completed |
Novartis |
2011-08-31 |
| NCT00922883 |
A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients |
https://ClinicalTrials.gov/show/NCT00922883 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2013-05-07 |
| NCT00914927 |
Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures |
https://ClinicalTrials.gov/show/NCT00914927 |
Completed |
Eisai Inc. |
2011-11-11 |
| NCT00908037 |
Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP) |
https://ClinicalTrials.gov/show/NCT00908037 |
Completed |
GlaxoSmithKline |
2014-02-01 |
| NCT00907478 |
Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) |
https://ClinicalTrials.gov/show/NCT00907478 |
Completed |
Amgen |
2014-01-09 |
| NCT00903929 |
Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation |
https://ClinicalTrials.gov/show/NCT00903929 |
Completed |
University of Rochester |
2015-12-31 |
| NCT00903422 |
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS) |
https://ClinicalTrials.gov/show/NCT00903422 |
Completed |
GlaxoSmithKline |
2012-06-26 |
| NCT00902018 |
Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP) |
https://ClinicalTrials.gov/show/NCT00902018 |
Completed |
Weill Medical College of Cornell University |
2015-09-07 |
| NCT00861692 |
Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II |
https://ClinicalTrials.gov/show/NCT00861692 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2011-02-28 |
| NCT04200456 |
A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT04200456 |
Recruiting |
UCB Pharma |
2021-12-31 |
| NCT04437953 |
Avatrombopag for Thrombocytopenia in People With Cancer |
https://ClinicalTrials.gov/show/NCT04437953 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-05-31 |
| NCT01349790 |
Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT01349790 |
Completed |
Octapharma |
2013-07-31 |
| NCT04371939 |
Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome |
https://ClinicalTrials.gov/show/NCT04371939 |
Recruiting |
Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
2022-12-31 |
| NCT04070599 |
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura. |
https://ClinicalTrials.gov/show/NCT04070599 |
Completed |
University Hospital, Bordeaux |
2014-03-05 |
| NCT02760251 |
Immunomodulation With Romiplostim in Young Adults With ITP |
https://ClinicalTrials.gov/show/NCT02760251 |
Completed |
University Hospital, Basel, Switzerland |
2019-07-31 |
| NCT04225156 |
A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP). |
https://ClinicalTrials.gov/show/NCT04225156 |
Recruiting |
argenx BVBA |
2022-06-30 |
| NCT04188379 |
A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP). |
https://ClinicalTrials.gov/show/NCT04188379 |
Recruiting |
argenx BVBA |
2021-06-06 |
| NCT02279173 |
Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP) |
https://ClinicalTrials.gov/show/NCT02279173 |
Completed |
Amgen |
2018-08-30 |
| NCT02052882 |
Study of Romiplostim for Chemotherapy Induced Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT02052882 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-01-31 |
| NCT04324060 |
A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT04324060 |
Active, not recruiting |
Peking Union Medical College Hospital |
2022-03-01 |
| NCT03809481 |
An Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban |
https://ClinicalTrials.gov/show/NCT03809481 |
Active, not recruiting |
Aspen Global Incorporated |
2021-01-31 |
| NCT03688191 |
Study of Sirolimus in CTD-TP in China |
https://ClinicalTrials.gov/show/NCT03688191 |
Active, not recruiting |
Peking Union Medical College Hospital |
2018-12-31 |
| NCT03998982 |
Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP |
https://ClinicalTrials.gov/show/NCT03998982 |
Recruiting |
Shandong University |
2020-04-01 |
| NCT00774358 |
Interleukin-2 Treatment for Wiskott-Aldrich Syndrome |
https://ClinicalTrials.gov/show/NCT00774358 |
Completed |
Children’s Hospital of Philadelphia |
2016-09-30 |
| NCT00771810 |
Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer |
https://ClinicalTrials.gov/show/NCT00771810 |
Completed |
Tarix Pharmaceuticals |
2011-12-31 |
| NCT00759083 |
Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients |
https://ClinicalTrials.gov/show/NCT00759083 |
Completed |
The Medicines Company |
2009-09-30 |
| NCT00735930 |
Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
https://ClinicalTrials.gov/show/NCT00735930 |
Completed |
National Cancer Institute (NCI) |
2013-03-31 |
| NCT00730314 |
Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells |
https://ClinicalTrials.gov/show/NCT00730314 |
Completed |
Children’s Hospital Los Angeles |
2015-08-31 |
| NCT00614523 |
Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) |
https://ClinicalTrials.gov/show/NCT00614523 |
Completed |
Amgen |
2011-03-31 |
| NCT00608738 |
Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment |
https://ClinicalTrials.gov/show/NCT00608738 |
Completed |
Northwestern University |
2005-01-31 |
| NCT00515203 |
Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects |
https://ClinicalTrials.gov/show/NCT00515203 |
Completed |
Amgen |
2009-03-31 |
| NCT00508820 |
An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP |
https://ClinicalTrials.gov/show/NCT00508820 |
Completed |
Amgen |
2011-01-01 |
| NCT00493181 |
Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients |
https://ClinicalTrials.gov/show/NCT00493181 |
Completed |
M.D. Anderson Cancer Center |
2011-01-31 |
| NCT00489437 |
Heparin-Induced Thrombocytopenia Score Card Study |
https://ClinicalTrials.gov/show/NCT00489437 |
Completed |
McMaster University |
2013-02-28 |
| NCT00472290 |
Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) |
https://ClinicalTrials.gov/show/NCT00472290 |
Completed |
Amgen |
2011-07-18 |
| NCT00418665 |
A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid |
https://ClinicalTrials.gov/show/NCT00418665 |
Completed |
Amgen |
2009-03-31 |
| NCT00415532 |
Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura |
https://ClinicalTrials.gov/show/NCT00415532 |
Completed |
Amgen |
2008-11-07 |
| NCT00413283 |
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) |
https://ClinicalTrials.gov/show/NCT00413283 |
Completed |
Amgen |
2008-12-31 |
| NCT00412464 |
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis |
https://ClinicalTrials.gov/show/NCT00412464 |
Completed |
FDA Office of Orphan Products Development |
2009-06-30 |
| NCT00367588 |
Low Bacterial Diet in Patients With Cytopenia |
https://ClinicalTrials.gov/show/NCT00367588 |
Completed |
Maastricht University Medical Center |
NA |
| NCT00358540 |
Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide |
https://ClinicalTrials.gov/show/NCT00358540 |
Completed |
GlaxoSmithKline |
2010-10-22 |
| NCT00344149 |
Rituximab as Second Line Treatment for ITP |
https://ClinicalTrials.gov/show/NCT00344149 |
Completed |
Ostfold Hospital Trust |
2014-03-31 |
| NCT00321711 |
Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents |
https://ClinicalTrials.gov/show/NCT00321711 |
Completed |
Amgen |
2009-10-19 |
| NCT00305708 |
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission |
https://ClinicalTrials.gov/show/NCT00305708 |
Completed |
University of California, San Francisco |
2004-07-31 |
| NCT00305435 |
Safety Study of AMG 531 in Japanese Subjects With ITP |
https://ClinicalTrials.gov/show/NCT00305435 |
Completed |
Kyowa Kirin Co., Ltd. |
2006-11-30 |
| NCT00303472 |
Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) |
https://ClinicalTrials.gov/show/NCT00303472 |
Completed |
Amgen |
2008-05-31 |
| NCT00301834 |
Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00301834 |
Completed |
University of California, San Francisco |
2011-09-30 |
| NCT00295971 |
Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease |
https://ClinicalTrials.gov/show/NCT00295971 |
Completed |
University of California, San Francisco |
2011-12-31 |
| NCT00283439 |
A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma |
https://ClinicalTrials.gov/show/NCT00283439 |
Completed |
Amgen |
2008-05-31 |
| NCT00263809 |
Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products |
https://ClinicalTrials.gov/show/NCT00263809 |
Completed |
Terumo BCTbio |
2007-10-31 |
| NCT00261924 |
Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days |
https://ClinicalTrials.gov/show/NCT00261924 |
Completed |
Cerus Corporation |
2009-07-31 |
| NCT00260689 |
Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00260689 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-05-04 |
| NCT00244010 |
Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias |
https://ClinicalTrials.gov/show/NCT00244010 |
Completed |
St. Jude Children’s Research Hospital |
2008-11-30 |
| NCT00220311 |
A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT00220311 |
Completed |
Sanofi |
2005-09-30 |
| NCT00198588 |
Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT00198588 |
Completed |
Ministry of Health, Labour and Welfare, Japan |
2006-07-31 |
| NCT00194987 |
A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT00194987 |
Completed |
Weill Medical College of Cornell University |
2015-06-30 |
| NCT00151866 |
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma |
https://ClinicalTrials.gov/show/NCT00151866 |
Completed |
Sanquin Research & Blood Bank Divisions |
NA |
| NCT00116688 |
Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) |
https://ClinicalTrials.gov/show/NCT00116688 |
Completed |
Amgen |
2010-01-31 |
| NCT00128713 |
Optimal Platelet Dose Strategy for Management of Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT00128713 |
Completed |
HealthCore-NERI |
2008-01-31 |
| NCT00110799 |
SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C |
https://ClinicalTrials.gov/show/NCT00110799 |
Completed |
GlaxoSmithKline |
2006-10-31 |
| NCT00102726 |
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT00102726 |
Completed |
GlaxoSmithKline |
2007-02-28 |
| NCT00102336 |
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy |
https://ClinicalTrials.gov/show/NCT00102336 |
Completed |
Amgen |
2006-12-01 |
| NCT00102323 |
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy |
https://ClinicalTrials.gov/show/NCT00102323 |
Completed |
Amgen |
2006-09-01 |
| NCT00004215 |
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00004215 |
Completed |
Memorial Sloan Kettering Cancer Center |
2000-08-31 |
| NCT00002665 |
SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00002665 |
Completed |
Southwest Oncology Group |
2001-12-31 |
| NCT00003619 |
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00003619 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00073580 |
Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) |
https://ClinicalTrials.gov/show/NCT00073580 |
Completed |
The Medicines Company |
2005-09-30 |
| NCT00031980 |
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00031980 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-05-31 |
| NCT00012376 |
Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer |
https://ClinicalTrials.gov/show/NCT00012376 |
Completed |
National Cancer Institute (NCI) |
2010-01-31 |
| NCT00001533 |
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine |
https://ClinicalTrials.gov/show/NCT00001533 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00049725 |
Daclizumab to Treat Chronic Immune Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT00049725 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00043940 |
Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) |
https://ClinicalTrials.gov/show/NCT00043940 |
Completed |
The Medicines Company |
2003-02-28 |
| NCT00039910 |
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT00039910 |
Completed |
Pfizer |
NA |
| NCT00039858 |
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin |
https://ClinicalTrials.gov/show/NCT00039858 |
Completed |
Encysive Pharmaceuticals |
NA |
| NCT00038311 |
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT00038311 |
Completed |
Pfizer |
NA |
| NCT00037791 |
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT00037791 |
Completed |
Pfizer |
NA |
| NCT00002258 |
A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia |
https://ClinicalTrials.gov/show/NCT00002258 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00004787 |
Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes |
https://ClinicalTrials.gov/show/NCT00004787 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00001630 |
Treatment of Autoimmune Thrombocytopenia (AITP) |
https://ClinicalTrials.gov/show/NCT00001630 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00004378 |
Stem Cell Transplantation (SCT) for Genetic Diseases |
https://ClinicalTrials.gov/show/NCT00004378 |
Completed |
National Center for Research Resources (NCRR) |
NA |